Skip to main content

Advertisement

Log in

Identification of Tumor-Associated Antigens from Medullary Breast Carcinoma by a Modified SEREX Approach

  • Research
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

Medullary breast carcinoma (MBC) is a relatively rare malignancy with heavy lymphocytic infiltration that despite cytologically anaplastic features and high mitotic index has more favorable prognosis than other types of breast cancer. Lymphocytic infiltration of tumors reflects ongoing immune response against tumor antigens which could represent a great interest as potential targets for cancer immunotherapy. The search for MBC antigens by SEREX methodology has not been successful due to a very high titer of false positive clones, representing immunoglobulin genes. Here, we describe a novel approach for generating cDNA expression libraries from MBC tumor samples which are depleted of IgG cDNA clones and, therefore, are suitable for the identification of novel tumor-associated antigens (TAA) by SEREX approach. Modified methodology allowed us to isolate a panel of known and novel TAA which are currently under further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Finn, O. J. (2008). Cancer immunology. New England Journal of Medicine, 358, 2704–2715.

    Article  CAS  Google Scholar 

  2. Mattes, M. J., Look, K., Furukawa, K., Pierce, V. K., Old, L. J., Lewis, J. L., et al. (1987). Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells. Cancer Research, 47, 6741–6750.

    CAS  Google Scholar 

  3. Boon, T., Couli, P. G., & Van den Eynde, B. (1997). Tumor antigens recognized by T cells. Immunology Today, 18, 267–268.

    Article  CAS  Google Scholar 

  4. Boon, T. (1993). Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. International Journal of Cancer, 54, 177–180.

    Article  CAS  Google Scholar 

  5. Parkhurst, M. R., Fitzgerald, E. B., Southwood, S., Sette, A., Rosenberg, S. A., & Kawakami, Y. (1998). Identification of a shared HLA by A0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Research, 58, 4895–4901.

    CAS  Google Scholar 

  6. Wang, R. F., Wang, X., Atwood, A. C., Topalian, S. L., & Rosenberg, S. A. (1999). Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Science, 284, 1351–1354.

    Article  CAS  Google Scholar 

  7. Gunawardana, C. G., & Diamandis, E. P. (2007). High throughput proteomic strategies for identifying tumour-associated antigens. Cancer Letters, 249, 110–119.

    Article  CAS  Google Scholar 

  8. Sahin, U., Tureci, O., & Pfreundschuh, M. (1997). Serological identification of human tumor antigens. Current Opinion Immunology, 9, 709–716.

    Article  CAS  Google Scholar 

  9. Old, L. J. (2008). Cancer vaccines: An overview. Cancer Immunity, 8(Suppl 1), 1.

    Google Scholar 

  10. Ridolfi, R. L., Rosen, P. P., Port, A., Kinne, D., & Mike, V. (1977). Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer, 40, 1365–1385.

    Article  CAS  Google Scholar 

  11. Kuroda, H., Tamaru, J., Sakamoto, G., Ohnisi, K., & Itoyama, S. (2005). Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Archiv, 446, 10–14.

    Article  Google Scholar 

  12. Hansen, M. H., Nielsen, H. V., & Ditzel, H. J. (2002). Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells. Journal of Immunology, 169, 2701–2711.

    CAS  Google Scholar 

  13. Kotlan, B., Simsa, P., Teillaud, J. L., Fridman, W. H., Toth, J., McKnight, M., et al. (2005). Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes. Journal of Immunology, 175, 2278–2285.

    CAS  Google Scholar 

  14. Hansen, M. H., Nielsen, H., & Ditzel, H. J. (2001). The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells. Proceedings of the National Academy of Science, 98, 12659–12664.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported in part by a grant from the National Academy of Sciences of Ukraine and the UICC fellowship to carry out some experiments on this project at University College London (UCL), United Kingdom.

Conflicts of Interest Statement

The authors declare no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ramziya Kiyamova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiyamova, R., Kostianets, O., Malyuchik, S. et al. Identification of Tumor-Associated Antigens from Medullary Breast Carcinoma by a Modified SEREX Approach. Mol Biotechnol 46, 105–112 (2010). https://doi.org/10.1007/s12033-010-9285-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-010-9285-2

Keywords

Navigation